Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia

Basic Research in Cardiology

Volumn 107, Issue 2, 2012, Pages

  Lassaletta, Antonio D ^a   Chu, Louis M ^a   Robich, Michael P ^a   Elmadhun, Nassrene Y ^a   Feng, Jun ^a   Burgess, Thomas A ^a   Laham, Roger J ^b   Sturek, Michael ^c   Sellke, Frank W ^a  

^a BROWN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardioprotection; Chronic ischemia; Metabolic syndrome; Ossabaw

Indexed keywords

CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VASCULOTROPIN; ANTIDIABETIC AGENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERIOLE DENSITY; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL PARAMETERS; BLOOD VESSEL REACTIVITY; CALORIC INTAKE; CAPILLARY DENSITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY COLLATERAL CIRCULATION; CORRELATION ANALYSIS; FATTY ACID METABOLISM; GLUCOSE INTOLERANCE; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID DIET; METABOLIC SYNDROME X; MICROVASCULATURE; MINIPIG; NONHUMAN; OVERNUTRITION; OXIDATION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SWINE; WEIGHT GAIN; ANIMAL; COLLATERAL CIRCULATION; CORONARY BLOOD VESSEL; DRUG EFFECT; HEMODYNAMICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; COLLATERAL CIRCULATION; CORONARY VESSELS; DIET, HIGH-FAT; HEMODYNAMICS; HYPOGLYCEMIC AGENTS; METABOLIC SYNDROME X; METFORMIN; MYOCARDIAL ISCHEMIA; SWINE; SWINE, MINIATURE;

EID: 84859713764     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0243-y     Document Type: Article

References (37)

1. Belin de Chantemele EJ, Irfan Ali M, Mintz J, Stepp DW (2009) Obesity-induced insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia. Basic Res Cardiol 104:707-717. doi:10.1007/s00395-009-0062-y
2. Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH (2009) Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234:683-692. doi:10.3181/0812-RM-350
3. Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM, Yellon DM (2008) Metformin protectsthe ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol 103:274-284. doi:10.1007/s00395-007-0691-y
4. Boodhwani M, Nakai Y, Mieno S, Voisine P, Bianchi C, Araujo EG, Feng J, Michael K, Li J, Sellke FW (2006) Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg 81:634-641. doi:10.1016/j.athoracsur. 2005.07.090 (Pubitemid 43120569)
5. Boodhwani M, Sodha NR, Mieno S, Ramlawi B, Xu SH, Feng J, Clements RT, Ruel M, Sellke FW (2007) Insulin treatment enhances the myocardial angiogenic response in diabetes. J Thorac Cardiovasc Surg 134:1453-1460. doi:10.1016/j.jtcvs.2007.08.025 (discussion 1460) (Pubitemid 350101614)
6. Boodhwani M, Sodha NR, Mieno S, Xu SH, Feng J, Ramlawi B, Clements RT, Sellke FW (2007) Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation 116:I31-I37. doi: 10.1161/CIRCULATIONAHA.106.680157 (Pubitemid 47480767)
7. Borbouse L, Dick GM, Payne GA, Payne BD, Svendsen MC, Neeb ZP, Alloosh M, Bratz IN, Sturek M, Tune JD (2010) Contribution of BK(Ca) channels to local metabolic coronary vasodilation: effects of metabolic syndrome. Am J Physiol Heart Circ Physiol 298:H966-H973. doi:10.1152/ajpheart.00876.2009
8. Chu LM, Robich MP, Lassaletta AD, Feng J, Laham RJ, Burgess T, Clements RT, Sellke FW (2011) Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia. Surgery 150:390-399. doi:10.1016/j.surg. 2011.06.009
9. Clements RT, Sodha NR, Feng J, Boodhwani M, Liu Y, Mieno S, Khabbaz KR, Bianchi C, Sellke FW (2009) Impaired coronary microvascular dilation correlates with enhanced vascular smooth muscle MLC phosphorylation in diabetes. Microcirculation 16:193-206. doi:10.1080/10739680802461950
10. de Groot D, Pasterkamp G, Hoefer IE (2009) Cardiovascular risk factors and collateral artery formation. Eur J Clin Invest 39:1036-1047. doi:10.1111/j.1365-2362.2009.02205.x
11. Dohner JW (2001) The encyclopedia of historic and endangered livestock and poultry breeds. Yale University Press
12. Hattan N, Chilian WM, Park F, Rocic P (2007) Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD. Basic Res Cardiol 102:217-223. doi:10.1007/ s00395-007-0646-3 (Pubitemid 46564070)
13. Iliadis F, Kadoglou N, Didangelos T (2011) Insulin and the heart. Diabetes Res Clin Pract 93(Suppl 1):S86-S91. doi:10.1016/ S0168-8227(11)70019-5
14. Katz PS, Trask AJ, Souza-Smith FM, Hutchinson KR, Galantowicz ML, Lord KC, Stewart JA Jr, Cismowski MJ, Varner KJ, Lucchesi PA (2011) Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Res Cardiol 106:1123-1134. doi:10.1007/s00395-011-0201-0
15. Lassaletta AD, Chu LM, Sellke FW (2011) Therapeutic neovascularization for coronary disease: current state and future prospects. Basic Res Cardiol 106:897-909. doi:10.1007/s00395-011-0200-1
16. Li Z, Woollard JR, Wang S, Korsmo MJ, Ebrahimi B, Grande JP, Textor SC, Lerman A, Lerman LO (2011) Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Renal Physiol 301:F1078-F1087. doi:10.1152/ajprenal. 00333.2011
17. Liepinsh E, Skapare E, Svalbe B, Makrecka M, Cirule H, Dambrova M (2011) Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats. Eur J Pharmacol 658:277-283. doi:10.1016/j.ejphar.2011.02.019
18. Liu Y, Gutterman DD (2009) Vascular control in humans: focus on the coronary microcirculation. Basic Res Cardiol 104:211-227. doi:10.1007/s00395- 009-0775-y
19. Lloyd PG, Fang M, Brisbin ILJ, Anderson L, Sturek M (2006) AMP kinase gene mutation is consistent with a thrifty phenotype (metabolic syndrome) in a population of feral swine. FASEB J 20:A299
20. Maejima Y, Okada H, Haraguchi G, Onai Y, Kosuge H, Suzuki J, Isobe M (2011) Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma. Lab Invest 91:932-944. doi:10.1038/labinvest.2011.45
21. Moreno-Navarrete JM, Ortega FJ, Rodriguez-Hermosa JI, Sabater M, Pardo G, Ricart W, Fernandez-Real JM (2011) OCT1 expression in adipocytes could contribute to increased metformin action in obese subjects. Diabetes 60:168-176. doi:10.2337/db10-0805
22. Neeb ZP, Edwards JM, Alloosh M, Long X, Mokelke EA, Sturek M (2010) Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med 60:300-315
23. Oltman CL, Richou LL, Davidson EP, Coppey LJ, Lund DD, Yorek MA (2006) Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 291:H1780-H1787. doi: 10.1152/ajpheart.01297.2005 (Pubitemid 44497684)
24. Orlandi A, Chavakis E, Seeger F, Tjwa M, Zeiher AM, Dimmeler S (2010) Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 105:703-712. doi:10.1007/s00395-010-0109-0
25. Park Y, Yang J, Zhang H, Chen X, Zhang C (2011) Effect of PAR2 in regulating TNF-alpha and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice. Basic Res Cardiol 106:111-123. doi:10.1007/s00395-010-0129-9
26. Petznick A (2011) Insulin management of type 2 diabetes mellitus. Am Fam Physician 84:183-190
27. Robich MP, Osipov RM, Nezafat R, Feng J, Clements RT, Bianchi C, Boodhwani M, Coady MA, Laham RJ, Sellke FW (2010) Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation 122:S142-S149. doi:10.1161/CIRCULATIONAHA. 109.920132
28. Schaper W (2009) Collateral circulation: past and present. Basic Res Cardiol 104:5-21. doi:10.1007/s00395-008-0760-x
29. Setty S, Sun W, Tune JD (2003) Coronary blood flow regulation in the prediabetic metabolic syndrome. Basic Res Cardiol 98:416-423. doi:10.1007/s00395-003-0418-7 (Pubitemid 37336629)
30. Sodha NR, Boodhwani M, Clements RT, Xu SH, Khabbaz KR, Sellke FW (2008) Increased antiangiogenic protein expression in the skeletal muscle of diabetic swine and patients. Arch Surg 143:463-470. doi:10.1001/archsurg.143.5.463 (Pubitemid 351717438)
31. Sodha NR, Clements RT, Boodhwani M, Xu SH, Laham RJ, Bianchi C, Sellke FW (2009) Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol 296:H428-H434. doi:10.1152/ ajpheart.00283.2008
32. Spurlock ME, Gabler NK (2008) The development of porcine models of obesity and the metabolic syndrome. J Nutr 138:397-402 (Pubitemid 351213658)
33. Varga O, Harangi M, Olsson IA, Hansen AK (2010) Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview. Obes Rev 11:792-807. doi:10.1111/j. 1467-789X.2009.00667.x
34. Volzke H, Henzler J, Menzel D, Robinson DM, Hoffmann W, Vogelgesang D, John U, Motz W, Rettig R (2007) Outcome after coronary artery bypass graft surgery, coronary angioplasty and stenting. Int J Cardiol 116:46-52. doi:10.1016/j.ijcard.2006.02.008 (Pubitemid 46227605)
35. Wolkart G, Schrammel A, Dorffel K, Haemmerle G, Zechner R, Mayer B (2011) Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARalpha agonist. Br J harmacol. doi:10.1111/j.1476-5381.2011.01490.x (Epub ahead of print)
36. Ye Y, Perez-Polo JR, Aguilar D, Birnbaum Y (2011) The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury. Basic Res Cardiol 106:925-952. doi: 10.1007/s00395-011-0216-6
37. Zhang H, Potter BJ, Cao JM, Zhang C (2011) Interferon-gamma induced adipose tissue inflammation is linked to endothelial dysfunction in type 2 diabetic mice. Basic Res Cardiol 106: 1135-1145. doi:10.1007/s00395-011-0212-x